Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease
Chronic hepatitis B has highly a dynamic course with significant fluctuations of HBV-DNA and ALT impeding assessment of disease activity. New biomarkers of inflammatory versus noninflammatory stages of HBV infection are urgently needed. Cytokeratin 18 epitope M30 (M30 CK-18) is a sensitive marker of...
Saved in:
| Main Authors: | Magdalena Świderska, Jerzy Jaroszewicz, Anna Parfieniuk-Kowerda, Magdalena Rogalska-Płońska, Agnieszka Stawicka, Anatol Panasiuk, Robert Flisiak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2017/3480234 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver disease
by: Elżbieta Supruniuk, et al.
Published: (2025-08-01) -
Expression of Cytokeratin (Ck) 7, Cytokeratin (Ck) 18, Carcinoembryonic Antigen (Cea) and Alpha Fetoprotein (Afp) In Liver Diseases
by: Shema, F.B.*, Adisa J.O.
Published: (2020-03-01) -
Expression of cytokeratins 5/6 and cytokeratin 17 in invasive breast carcinoma
by: Ivković-Kapicl Tatjana, et al.
Published: (2012-01-01) -
Elevated Serum Level of Cytokeratin 18 M65ED Is an Independent Indicator of Cardiometabolic Disorders
by: Lingling Qian, et al.
Published: (2020-01-01) -
Serum Cytokeratin 18 Fragment Is an Indicator for Treating Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Miwa Kawanaka, et al.
Published: (2024-01-01)